Novira Therapeutics' Series A - II Round

Novira Therapeutics raised a round of funding on March 25, 2013. Investors include Versant Ventures.

Novira Therapeutics is an antiviral drug discovery company that is focused on the discovery of first-in-class antiviral therapeutics for the treatment of chronic HBV and HIV infections, two global dis…

Articles about Novira Therapeutics' Series A - II Round: